projects

SL NO

PROJECT TITLE

FUNDING AGENCY

DURATION

        1

Immunologic and Immunogenetic aspects of Multiple sclerosis patients in India   

ICMR

1987 to 1990

Purine metabolic enzymes in peripheral blood T-cells in Multiple sclerosis patients

ICMR

1997 to 2000

1. 3 

Antioxidant status and genetically determined differences in xenobiotic  metabolism in Parkinsons disease

ICMR

1999 to 2002

1. 4

Role of CYP2D6 and Glutathione S-transferase M1 (GSTM1) polymorphism in Multiple Sclerosis patients

ICMR

2001 to 2003

1.  5

Impact of Nutritional strategies and antioxidant therapy on progression and  management of Parkinson,s disease

ICMR

2002 to 2004

1.  6

Molecular study on mitochondrial dysfunction in Parkinson,s disease 

ICMR

2004 to 2006

1.  7

Genetic polymorphism of drug metabolizing enzymes CYPC9 and CYPC19 genes in patients developing adverse drug reactions and toxicity to specific antiepileptic drug - Phenytoin

ICMR

2004 to 2007

1.  8

To find out predominant mutation(s) in Cu/Zn SOD1 gene in Familial amyotrophic  lateral sclerosis patients and their first –degree relatives in Indian population

AIIMS

2006 to 2007

1.  9

Health Profile of Population of Nellore  (A.P.) An ICMR task force study.

ICMR

2007 to 2008

10    10

Analysis of TGF B Pathway components expression and mutation in   glioma patients “

AIIMS

2007 to 2008

11    11

Health Profile of Population of Dhar (MP)

ICMR

2009 to 2010

1 .    12

Pharmacogenetic of epilepsy drug therapeutics

DBT

2007 to 2010

13    13

The study of mitochondrial dysfunction in patients with Amyotrophic Lateral  Sclerosis

ICMR

2007 to 2010

14   14

Validation of Gel dosimetry as 3D verification tool for highly conformal radiotherapy techniques

AERB

2009 to 2010

15     15   

Exploring the role of MHC and co-stimulatory molecules in immune evasion mechanism of Glioma stem cells.

DBT

2008 to 2011

16   16

Pharmacogenetics of Alzhemiers drug therapeutics

DST

2010 to 2014

17   17

Multi centric study on Pharmacogenetics of Schizophrenia drug therapeutics

ICMR

2011to 2015